앨라배마의 제2형 당뇨병 임상 시험
제2형 당뇨병 관련 연구 22개가 앨라배마 내 여러 지역에서 참여자를 모집하고 있습니다.
앨라배마의 도시
공식 연구 텍스트(영어)
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Heart Center Research, LLC, Huntsville
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07783802A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Fairhope
- Research Site, Huntsville
- Research Site, Mobile
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07784270A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Birmingham Clinical Research, Birmingham
- Cullman Clinical Trials, Cullman
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07282600A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Cahaba Research, Inc. - Trussville Location, Birmingham
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07754461A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Birmingham
- AURORA-2 Clinical Site, Huntsville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT07743450EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Pinnacle Research Group, LLC, Anniston
- Eastern Shore Research Group, Fairhope
- Lakeview Clinical Research, Guntersville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT07064473A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
- Central Research Associates - Flourish - PPDS, Birmingham
- AES - DRS - Synexus Clinical Research US, Inc. - Birmingham, Birmingham
- AES - DRS - Optimal Research Alabama - Huntsville, Huntsville
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT07340320A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Lakeview Clinical Research, Guntersville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT07351058Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- Apogee Clinical Research, LLC, Huntsville
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT07271186A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- Flourish Research, Birmingham
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT07668388A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Birmingham
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT07662213Advancing Diabetes Management for People With Physical Disabilities Optimally Through Primary Care-Based Telehealth (ADDOPT)
- UAB Highlands Hospital/Department of Family and Community Medicine, Birmingham
피험자 모집 중
18세 ~ 89세 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT07032844AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Univ of Alabama Birmingham, Birmingham
- Eastern Shore Rsrch Inst, LLC, Fairhope
- Chambliss Clinical Trials, LLC, Montgomery
피험자 모집 중3상
45세 이상 · 모든 성별 · 2026. 9. 1. 업데이트됨 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Huntsville
- Research Site, Mobile
- Research Site, Sheffield
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 31. 업데이트됨 · NCT07662109A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Birmingham
- Research Site, Daphne
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 31. 업데이트됨 · NCT07662044CGM for Management of Type 2 Diabetes in Pregnancy
- University of Alabama at Birmingham, Birmingham
피험자 모집 중
18세 ~ 50세 · 여성 · 2026. 6. 29. 업데이트됨 · NCT06628453Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
- University of Alabama, Birmingham
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 6. 16. 업데이트됨 · NCT06906627Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
- University of Alabama, Birmingham
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 6. 16. 업데이트됨 · NCT06906640Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
- Central Research Associates, LLC dba Flourish Research, Birmingham
피험자 모집 중2상
18세 ~ 70세 · 모든 성별 · 2026. 6. 15. 업데이트됨 · NCT07502508DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
- University of Alabama at Birmingham, Birmingham
피험자 모집 중관찰 연구
8세 ~ 15세 · 모든 성별 · 2026. 5. 7. 업데이트됨 · NCT06525259FELLAShip to Better Health
- The Worship Center Cristian Church, Birmingham
피험자 모집 중
18세 이상 · 남성 · 2026. 1. 22. 업데이트됨 · NCT07220213A Low-Carb Approach to Treat Type 2 Diabetes in Pediatric Patients
- University of Alabama at Birmingham/ Children's of Alabama, Birmingham
피험자 모집 중
12세 ~ 18세 · 모든 성별 · 2025. 12. 8. 업데이트됨 · NCT06902077ClinicalTrials.gov 출처, 2026. 9. 30. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.